The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Saved in:
| Title: | The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. |
|---|---|
| Authors: | Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Link BK; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Feldman AL; Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota, USA., Habermann TM; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Jaye DL; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA., Burack WR; Department of Pathology, University of Rochester, Rochester, New York, USA., McDonnell TJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chapman JR; Department of Pathology, Division of Hematopathology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Syrbu S; Department of Pathology, University of Iowa, Iowa City, Iowa, USA., Vij KR; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri, USA., Inghirami G; Department of Pathology, Weill Cornell Medicine, New York, New York, USA., Leonard JP; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Bernal-Mizrachi L; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Farooq U; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Witzig TE; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Weiner GJ; Department of Internal Medicine, Division of Hematology, Oncology, and Bone & Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA., Wang Y; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Alderuccio JP; Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Slager SL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Larson MC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Riska SM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Gysbers BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Lunde JJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Reicks TW; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Ayers AA; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., O'Leary CB; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Yost KJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Liu H; Department of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, Minnesota, USA., Nowakowski GS; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ruan J; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Koff JL; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, New York, USA., Thompson CA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., Cohen JB; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA., Kahl BS; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lossos IS; Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Friedberg JW; Department of Artificial Intelligence & Informatics, Mayo Clinic, Rochester, Minnesota, USA., Martin P; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Flowers CR; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 408-421. Date of Electronic Publication: 2024 Jan 13. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.27202 |
